IDEXX Laboratories/IDXX

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About IDEXX Laboratories

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.

Ticker

IDXX

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Westbrook, United States

Employees

11,000

IDXX Metrics

BasicAdvanced
$39B
Market cap
46.16
P/E ratio
$10.32
EPS
1.33
Beta
-
Dividend rate
$39B
1.33
1.57
1.02
46.189
68.133
30.68%
22.63%
71.91%
46.16
10.63
25.04
37.6
49.68
8.57%
24.27%
9.23%
9.92%

What the Analysts think about IDXX

Analyst Ratings

Majority rating from 13 analysts.
Buy

IDXX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
24.42% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$964M
6.92%
Net income
$236M
21.08%
Profit margin
24.42%
13.21%

IDXX Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 5.16%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$2.67
$2.53
$2.32
$2.81
-
Expected
$2.47
$2.37
$2.12
$2.67
$2.87
Surprise
8.19%
6.75%
9.46%
5.16%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for IDEXX Laboratories stock?

IDEXX Laboratories (IDXX) has a market cap of $39B as of July 03, 2024.

What is the P/E ratio for IDEXX Laboratories stock?

The price to earnings (P/E) ratio for IDEXX Laboratories (IDXX) stock is 46.16 as of July 03, 2024.

Does IDEXX Laboratories stock pay dividends?

No, IDEXX Laboratories (IDXX) stock does not pay dividends to its shareholders as of July 03, 2024.

When is the next IDEXX Laboratories dividend payment date?

IDEXX Laboratories (IDXX) stock does not pay dividends to its shareholders.

What is the beta indicator for IDEXX Laboratories?

IDEXX Laboratories (IDXX) has a beta rating of 1.33. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell IDEXX Laboratories stock

Buy or sell IDEXX Laboratories stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing